Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
identity or expression (whether actual or perceived), sexual orientation, age, height, weight, disability, citizenship status, veteran status, HIV antibody status, political belief, membership in any social
-
multidisciplinary, NIH-funded research program at the interface of molecular imaging, antibody engineering, cancer biology, drug development, and translational oncology. Our laboratory develops next-generation
-
on the second floor of the D-wing at UW Medical Center-Northwest, which is just off I-5 in North Seattle. Our clinic treats a broad range of conditions with chimeric monoclonal antibodies, anti-inflammatory tumor
-
IRCM - Cancer Research Institute of Montpellier | Montpellier, Languedoc Roussillon | France | 3 months ago
dedicated to developing new antibody-based biotherapies and diagnostic tools for solid tumors, auto-immune diseases and emerging viruses. The team uses in vitro selection approaches and home-made designed
-
(NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), autoimmune encephalitis, and other neuroimmunologic disorders Deliver comprehensive outpatient and inpatient
-
23 Jul 2026 Job Information Organisation/Company KU LEUVEN Department Therapeutic and Diagnostic Antibodies (KU Leuven) Research Field Neurosciences » Neurobiology Medical sciences » Medicine
-
. The Duke Laboratory for HIV-1 & COVID-19 Vaccine Research & Development is led by Drs. David Montefiori, PhD and Xiaoying (Shaunna) Shen, DVM, PhD. Our research focuses on neutralizing antibody
-
University of California, Los Angeles | Los Angeles, California | United States | about 14 hours ago
projects in the laboratory integrate whole-genome sequencing (WGS), transcriptomics, single-cell RNA sequencing, antibody and systems-serology measurements, PhIP-Seq/epitope profiling, immunophenotyping, and
-
transplant program. In addition, members of the Division have made substantial contributions to many other areas of cancer treatment, including the use of tumor vaccines, cellular therapy for cancer, antibody
-
suitable for the evaluation of biopharmaceuticals (antibodies, nanobodies, …) • Develop and validate protocols for the formation of multicellular liver organoids in microfluidic devices (hepatocytes, LSECs